Entrepreneurs raise DKK 10 million to help sperm quality test penetrate lucrative US market
Valby-based company Motilitycount, which obtained FDA approval for its sperm quality test last year, has raised DKK 10 million (USD 1.4 million) through new investors and debt conversion. The money makes it possible for the company to go from being a startup to a scaleup firm, the CEO says.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.